Budesonide Inhalant
Product Images NDC 0487-9701
Product Visual Gallery
This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 0487-9701). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nephron Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1: A 12-week Trial In Pediatric Patients Not On Inhaled Corticosteroid Therapy Prior To Study Entry. Nighttime Asthma Change From Baseline (Bud Fig 1)
Figure 1 (Budesonide 02)
Figure 3: A 12-week Trial In Pediatric Patients Either Maintained On Bronchodilators Alone Or Inhaled Corticosteroid Therapy Prior To Study Entry. Nighttime Asthma Change From Baseline. (Bud Fig 3)
Figure 1 And 1a (Figure 1 And 1.0a)
Figure 2 (Budesonide Ifu Figure 2.0)
Figure 3 (Budesonide Ifu Figure 3.0)
Figure 4 (Budesonide Ifu Figure 4.0)
Single Foil (547 Single)
Single Carton 1115 (Bud Single Cart 1115)
Card Foil (549 Card)
1118 Carton (1118 Carton Card New)
Single Foil (545 Singles)
Carton Single 1116 (Carton 1116)
Foil Card 550 (550 Card)
1117 Carton (1117 Carton Card New)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.